Actively Recruiting
Efficacy of Vonoprazan Based Dual and Triple Therapy for Patient With Helicobacter Pylori Infection
Led by Sohag University · Updated on 2025-07-01
150
Participants Needed
1
Research Sites
28 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to assess Efficacy of vonoprazan based dual and triple therapy for naïve patient with Helicopacter Pylori infection in Sohag Government .
CONDITIONS
Official Title
Efficacy of Vonoprazan Based Dual and Triple Therapy for Patient With Helicobacter Pylori Infection
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age: >18 years old.
- Confirmed Helicobacter pylori infection by histopathology or non-invasive tests (e.g., stool antigen test).
You will not qualify if you...
- Previous treatment for Helicobacter pylori infection.
- Known allergies to study medications or components.
- Inability to complete the treatment course.
- Missed follow-up visits.
- Refusal or neglect of test of cure for Helicobacter pylori.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sohag University Hospital
Sohag, Egypt
Actively Recruiting
Research Team
A
Andrew K Wadea, Resident
CONTACT
H
Hamdy S Mohammed, Professor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here